Next stage of growth with a new CEO

Resyca BV, an Enschede-based company, specialises in drug delivery using innovative soft-mist inhalation technology.  New CEO Deborah Jones is renowned as an expert in the complexities of inhaled and nasal drug delivery. She is set to lead the company into its next phase of growth, expand strategic collaborations with global partners in the pharmaceutical and biotech sectors, and further develop the platforms for soft-mist inhalers and nasal sprays. Another focus will be on strengthening Resyca’s position as a trusted partner in the development of integrated drug-device combinations.

To her new position, Jones brings more than 20 years of leadership experience in senior roles to this position. She has supported the international expansion of companies, the establishment of strategic partnerships and the scaling of technology platforms to achieve sustainable revenue growth. Prior to joining Resyca, Jones was responsible for business strategy at Proveris Scientific across the EMEA region and India, where she played a key role in the global launch of technologies for the characterisation of aerosols and sprays.